Page last updated: 2024-09-05

sb 203580 and thymosin

sb 203580 has been researched along with thymosin in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (thymosin)	Trials (thymosin)	Recent Studies (post-2010) (thymosin)
3,489	4	1,137	2,649	120	683

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gil, JE; Kim, JH; Moon, EY; Oh, SY; Song, JH; Yeom, YI	1

Other Studies

1 other study(ies) available for sb 203580 and thymosin

Article	Year
ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. Experimental cell research, 2006, May-15, Volume: 312, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Imidazoles; Mice; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Pyridines; ras Proteins; RNA, Small Interfering; Thymosin; Transfection	2006

Article

Year

ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance.

Experimental cell research, 2006, May-15, Volume: 312, Issue:9

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Imidazoles; Mice; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Pyridines; ras Proteins; RNA, Small Interfering; Thymosin; Transfection

2006